Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) will be announcing its earnings results before the market opens on Friday, November 3rd. Analysts expect the company to announce earnings of C$0.18 per share for the quarter.
Shares of Cipher Pharmaceuticals Inc (TSE CPH) opened at 4.33 on Wednesday. The stock’s market capitalization is $115.26 million. The company’s 50 day moving average is $4.53 and its 200-day moving average is $5.05. Cipher Pharmaceuticals Inc has a 52 week low of $3.50 and a 52 week high of $5.75.
Several analysts recently issued reports on the stock. TD Securities boosted their target price on shares of Cipher Pharmaceuticals from C$5.50 to C$6.50 in a research report on Monday, August 14th. Bloom Burton lowered shares of Cipher Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Monday, August 14th.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc, together with its subsidiaries, operates as a specialty pharmaceutical dermatology company in South America, Canada, and the United States. It offers CIP-ISOTRETINOIN, a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; CIP-FENOFIBRATE, a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and CIP-TRAMADOL ER, a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain.
What are top analysts saying about Cipher Pharmaceuticals Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cipher Pharmaceuticals Inc and related companies.